2-[5-(2-Methyl­phen­yl)-3-(2-methyl­styryl)-4,5-di­hydro-1H-pyrazol-1-yl]-6-(thio­phen-2-yl)-4-(tri­fluoro­meth­yl)pyrimidine chloro­form monosolvate

In the crystal structure of the title compound, C₂₈H₂₃F₃N₄S·CHCl₃, the chloro­form solvate mol­ecules connect the pyrimidine mol­ecules into chains along [101] through weak C—H...N and C—H...Cl hydrogen-bond inter­actions. There are further connections between adjacent chains through F...Cl halogen contacts of 3.185 (3) Å, with the –CF₃ group presenting a significant short F...F inter­chain distance of 2.712 (4) Å. The five-membered pyrazole ring is approximately planar (r.m.s. deviation = 0.050 Å). The pyrimidine ring makes dihedral angles of 84.15 (8) and 4.56 (8)° with the benzene rings.

Crystal structure of ethyl (E)-4-(4-chlorophen­yl)-4-meth­oxy-2-oxobut-3-enoate

In the title compound, C₁₃H₁₃ClO₄, the dihedral angle between the chloro­benezene ring and the least-squares plane through the 4-meth­oxy-2-oxobut-3-enoate ethyl ester residue (r.m.s. deviation = 0.0975 Å) is 54.10 (5)°. In the crystal, mol­ecules are connected by meth­oxy–ketone and benzene–carboxyl­ate carbonyl C—H...O inter­actions, generating a supra­molecular layer in the ac plane.